← Every company
Castle Biosciences Inc SEC Filings
What Castle Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
CSTL overview →Filings on file
100
since Jun 26, 2019
Warning signs
1
latest Mar 5, 2020
Last results
Jul 30, 2026
8-K item 2.02
Industry
Services-Medical Laboratories
SIC 8071
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Mar 5, 2020 | Debt acceleratedMaterial agreement 8-K | Read ↗ |
Source: Castle Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on CSTL
Company overviewEverything on CSTL in one place, with the price.Insider tradingWhat CSTL's own officers and directors buy and sell.Planned salesSales CSTL insiders have filed notice of.Executive payWhat CSTL awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in CSTL.Funds holding itWhich funds and ETFs hold CSTL, and how big a bet.LobbyingWhat CSTL spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on CSTL's account, and who they worked for.Federal contractsWhat federal agencies pay CSTL.PatentsWhat CSTL is filing at the patent office.